Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-24-000345
Filing Date
2024-06-04
Accepted
2024-06-04 16:06:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2827
  Complete submission text file 0001971857-24-000345.txt   4624
Mailing Address 2614 BOSTON POST ROAD SUITE #33B GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD SUITE #33B GUILFORD CT 06437 203-643-8002
BioXcel LLC (Reporting) CIK: 0001651990 (see all company filings)

EIN.: 202612128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38410 | Film No.: 241017984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)